Suzanne Dowson

6PUBLICATIONS
51CO-AUTHORS
Solid tumoursCancer geneticsGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 07, 2022
Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin.

Gwo Yaw Ho, Elizabeth L Kyran, Justin Bedo

|Mar 20, 2021
Structural Variants at the BRCA1/2 Loci are a Common Source of Homologous Repair Deficiency in High-grade Serous Ovarian Carcinoma.

Ailith Ewing, Alison Meynert, Michael Churchman

|Aug 15, 2018
Copy number signatures and mutational processes in ovarian carcinoma.

Geoff Macintyre, Teodora E Goranova, Dilrini De Silva

|Apr 14, 2018
Author Correction: CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity.

Josephine B Walton, Malcolm Farquharson, Susan Mason

|Dec 15, 2017
RIPK3 promotes adenovirus type 5 activity.

Melanie Weigert, Alex Binks, Suzanne Dowson

|Dec 06, 2017
CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity.

Josephine B Walton, Malcolm Farquharson, Susan Mason

Pageof 1

Frequent Collaborators

6 joint publications

Iain A McNeish

3 joint publications

Rosalind M Glasspool

2 joint publications

Daniel Murphy

2 joint publications

Seth Coffelt